These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18460258)

  • 1. Inflammatory bowel disease: treatment postulates and future prospects.
    Saeed SA; Zaidi AH
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):197. PubMed ID: 18460258
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel disease.
    Bantel H; Domschke W; Schulze-Osthoff K; Kaskas B; Gregor M
    Am J Gastroenterol; 2000 Jul; 95(7):1845-6. PubMed ID: 10926007
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease.
    De Iudicibus S; Stocco G; Martelossi S; Drigo I; Norbedo S; Lionetti P; Pozzi E; Barabino A; Decorti G; Bartoli F; Ventura A
    Gut; 2007 Sep; 56(9):1319-20. PubMed ID: 17698869
    [No Abstract]   [Full Text] [Related]  

  • 4. The 1,2,3-triazole ring as a peptido- and olefinomimetic element: discovery of click vanilloids and cannabinoids.
    Appendino G; Bacchiega S; Minassi A; Cascio MG; De Petrocellis L; Di Marzo V
    Angew Chem Int Ed Engl; 2007; 46(48):9312-5. PubMed ID: 17968870
    [No Abstract]   [Full Text] [Related]  

  • 5. Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammation.
    Schreiber S
    Gastroenterology; 2005 Nov; 129(5):1782-4. PubMed ID: 16285973
    [No Abstract]   [Full Text] [Related]  

  • 6. A gut feeling of the PXR, PPAR and NF-kappaB connection.
    Wahli W
    J Intern Med; 2008 Jun; 263(6):613-9. PubMed ID: 18479261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
    Calder PC
    Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats.
    Kopczyńska B
    Life Sci; 2008 Jul; 83(3-4):85-91. PubMed ID: 18572197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of vanilloid transient receptor potential cation channels.
    Vriens J; Appendino G; Nilius B
    Mol Pharmacol; 2009 Jun; 75(6):1262-79. PubMed ID: 19297520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain TRPV1: a depressing TR(i)P down memory lane?
    Di Marzo V; Gobbi G; Szallasi A
    Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating inflammatory bowel disease research into clinical medicine.
    Neurath MF; Finotto S
    Immunity; 2009 Sep; 31(3):357-61. PubMed ID: 19766078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
    Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
    J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor polymorphisms in inflammatory bowel disease.
    Decorti G; De Iudicibus S; Stocco G; Martelossi S; Drigo I; Bartoli F; Ventura A
    Gut; 2006 Jul; 55(7):1053-4. PubMed ID: 16766764
    [No Abstract]   [Full Text] [Related]  

  • 15. On the thermoregulatory perils of TRPV1 antagonism.
    Caterina MJ
    Pain; 2008 May; 136(1-2):3-4. PubMed ID: 18359567
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear factor-kappa B in intestinal protection and destruction.
    Spehlmann ME; Eckmann L
    Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
    Broom OJ; Nielsen OH
    Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of inflammatory bowel disease: transcription factors in the spotlight.
    Neurath MF
    Gut; 1998 Apr; 42(4):458-9. PubMed ID: 9616303
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of endocannabinoids in cardiovascular shock.
    Malinowska B; Lupinski S; Godlewski G; Baranowska U; Schlicker E
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 8():91-107. PubMed ID: 19258666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.